bf/NASDAQ:CRBU_icon.jpeg

COM:CARIBOUBIO

Caribou Biosciences

  • Stock

Last Close

1.96

21/11 17:59

Market Cap

153.54M

Beta: -

Volume Today

482.94K

Avg: -

Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed...Show More

peer of

investor of

competitor of